-
1
-
-
34047274279
-
Use of high-sensitivity CRP to predict first cardiovascular events
-
Stahl HD. Use of high-sensitivity CRP to predict first cardiovascular events. Lancet 2007; 369: 1259-1260.
-
(2007)
Lancet
, vol.369
, pp. 1259-1260
-
-
Stahl, H.D.1
-
2
-
-
75349095581
-
Preoperative NT-proBNP and CRP predict perioperative major cardiovascular events in non-cardiac surgery
-
Choi JH, Cho DK, Song YB, Hahn JY, Choi S, Gwon HC, Kim DK, Lee SH, Oh JK and Jeon ES. Preoperative NT-proBNP and CRP predict perioperative major cardiovascular events in non-cardiac surgery. Heart 2010; 96: 56-62.
-
(2010)
Heart
, vol.96
, pp. 56-62
-
-
Choi, J.H.1
Cho, D.K.2
Song, Y.B.3
Hahn, J.Y.4
Choi, S.5
Gwon, H.C.6
Kim, D.K.7
Lee, S.H.8
Oh, J.K.9
Jeon, E.S.10
-
3
-
-
28444484666
-
Increased levels of C-reactive protein and fibrinogen influence the risk of vascular events in patients with NIDDM
-
Coppola G, Corrado E, Muratori I, Tantillo R, Vitale G, Lo Coco L and Novo S. Increased levels of C-reactive protein and fibrinogen influence the risk of vascular events in patients with NIDDM. Int J Cardiol 2006; 106: 16-20.
-
(2006)
Int J Cardiol
, vol.106
, pp. 16-20
-
-
Coppola, G.1
Corrado, E.2
Muratori, I.3
Tantillo, R.4
Vitale, G.5
Lo Coco, L.6
Novo, S.7
-
4
-
-
33846639651
-
Value of serum glycated albumin and high-sensitivity C-re-active protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes
-
Pu LJ, Lu L, Xu XW, Zhang RY, Zhang Q, Zhang JS, Hu J, Yang ZK, Ding FH, Chen QJ, Lou S, Shen J, Fang DH and Shen WF. Value of serum glycated albumin and high-sensitivity C-re-active protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes. Cardiovasc Diabetol 2006; 5: 27.
-
(2006)
Cardiovasc Diabetol
, vol.5
, pp. 27
-
-
Pu, L.J.1
Lu, L.2
Xu, X.W.3
Zhang, R.Y.4
Zhang, Q.5
Zhang, J.S.6
Hu, J.7
Yang, Z.K.8
Ding, F.H.9
Chen, Q.J.10
Lou, S.11
Shen, J.12
Fang, D.H.13
Shen, W.F.14
-
5
-
-
37549022688
-
Inflammation and insulin resistance
-
de Luca C and Olefsky JM. Inflammation and insulin resistance. FEBS Lett 2008; 582: 97-105.
-
(2008)
FEBS Lett
, vol.582
, pp. 97-105
-
-
de Luca, C.1
Olefsky, J.M.2
-
6
-
-
78650209525
-
Insulin resistance in Chinese patients with type 2 diabetes is associated with C-reactive protein independent of abdominal obesity
-
Lu B, Yang Y, Yang Z, Feng X, Wang X, Zhang Z and Hu R. Insulin resistance in Chinese patients with type 2 diabetes is associated with C-reactive protein independent of abdominal obesity. Cardiovasc Diabetol 2010; 9: 92.
-
(2010)
Cardiovasc Diabetol
, vol.9
, pp. 92
-
-
Lu, B.1
Yang, Y.2
Yang, Z.3
Feng, X.4
Wang, X.5
Zhang, Z.6
Hu, R.7
-
7
-
-
18244364864
-
NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome
-
Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C, Karim R, Lin R, Samarasinghe D, Liddle C, Weltman M and George J. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002; 35: 373-379.
-
(2002)
Hepatology
, vol.35
, pp. 373-379
-
-
Chitturi, S.1
Abeygunasekera, S.2
Farrell, G.C.3
Holmes-Walker, J.4
Hui, J.M.5
Fung, C.6
Karim, R.7
Lin, R.8
Samarasinghe, D.9
Liddle, C.10
Weltman, M.11
George, J.12
-
8
-
-
3543029821
-
Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
-
Samuel VT, Liu ZX, Qu X, Elder BD, Bilz S, Befroy D, Romanelli AJ and Shulman GI. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem 2004; 279: 32345-32353.
-
(2004)
J Biol Chem
, vol.279
, pp. 32345-32353
-
-
Samuel, V.T.1
Liu, Z.X.2
Qu, X.3
Elder, B.D.4
Bilz, S.5
Befroy, D.6
Romanelli, A.J.7
Shulman, G.I.8
-
9
-
-
41549108440
-
Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children
-
Wang CL, Liang L, Fu JF, Zou CC, Hong F, Xue JZ, Lu JR and Wu XM. Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children. World J Gastroenterol 2008; 14: 1598-1602.
-
(2008)
World J Gastroenterol
, vol.14
, pp. 1598-1602
-
-
Wang, C.L.1
Liang, L.2
Fu, J.F.3
Zou, C.C.4
Hong, F.5
Xue, J.Z.6
Lu, J.R.7
Wu, X.M.8
-
10
-
-
0038544021
-
Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey
-
Shen L, Fan JG, Shao Y, Zeng MD, Wang JR, Luo GH, Li JQ and Chen SY. Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey. World J Gastroenterol 2003; 9: 1106-1110.
-
(2003)
World J Gastroenterol
, vol.9
, pp. 1106-1110
-
-
Shen, L.1
Fan, J.G.2
Shao, Y.3
Zeng, M.D.4
Wang, J.R.5
Luo, G.H.6
Li, J.Q.7
Chen, S.Y.8
-
11
-
-
8444242946
-
Non-alcoholic steatohepatitis
-
Jansen PL. Non-alcoholic steatohepatitis. Eur J Gastroenterol Hepatol 2004; 16: 1079-1085.
-
(2004)
Eur J Gastroenterol Hepatol
, vol.16
, pp. 1079-1085
-
-
Jansen, P.L.1
-
12
-
-
8744254513
-
Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course
-
Cortez-Pinto H and Camilo ME. Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course. Best Pract Res Clin Gastroenterol 2004; 18: 1089-1104.
-
(2004)
Best Pract Res Clin Gastroenterol
, vol.18
, pp. 1089-1104
-
-
Cortez-Pinto, H.1
Camilo, M.E.2
-
13
-
-
34249668818
-
Epidemiology and natural history of NAFLD and NASH
-
Ong JP and Younossi ZM. Epidemiology and natural history of NAFLD and NASH. Clin Liver Dis 2007; 11: 1-16, vii.
-
(2007)
Clin Liver Dis
, vol.11
-
-
Ong, J.P.1
Younossi, Z.M.2
-
14
-
-
62749144547
-
Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis
-
Serfaty L and Lemoine M. Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis. Diabetes Metab 2008; 34: 634-637.
-
(2008)
Diabetes Metab
, vol.34
, pp. 634-637
-
-
Serfaty, L.1
Lemoine, M.2
-
15
-
-
77953971188
-
Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years
-
Wong VW, Wong GL, Choi PC, Chan AW, Li MK, Chan HY, Chim AM, Yu J, Sung JJ and Chan HL. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut 2010; 59: 969-974.
-
(2010)
Gut
, vol.59
, pp. 969-974
-
-
Wong, V.W.1
Wong, G.L.2
Choi, P.C.3
Chan, A.W.4
Li, M.K.5
Chan, H.Y.6
Chim, A.M.7
Yu, J.8
Sung, J.J.9
Chan, H.L.10
-
16
-
-
44449139529
-
Carotid plaque, stroke pathogenesis, and CRP: treatment of ischemic stroke
-
Krupinski J, Turu MM, Slevin M and Martinez-Gonzalez J. Carotid plaque, stroke pathogenesis, and CRP: treatment of ischemic stroke. Curr Cardiol Rep 2008; 10: 25-30.
-
(2008)
Curr Cardiol Rep
, vol.10
, pp. 25-30
-
-
Krupinski, J.1
Turu, M.M.2
Slevin, M.3
Martinez-Gonzalez, J.4
-
17
-
-
78649672497
-
Admission C-reactive protein and short-as well as long-term mortality in diabetic versus non-diabetic patients with incident myocardial infarction
-
Meisinger C, Heier M, von Scheidt W and Kuch B. Admission C-reactive protein and short-as well as long-term mortality in diabetic versus non-diabetic patients with incident myocardial infarction. Clin Res Cardiol 2010; 99: 817-823.
-
(2010)
Clin Res Cardiol
, vol.99
, pp. 817-823
-
-
Meisinger, C.1
Heier, M.2
von Scheidt, W.3
Kuch, B.4
-
18
-
-
20244374140
-
C-reactive protein as predictor of death in end-stage diabetic nephropathy: role of peripheral arterial disease
-
Boger CA, Gotz A, Stubanus M, Banas B, Deinzer M, Kruger B, Holmer SR, Schmitz G, Riegger GA and Kramer BK. C-reactive protein as predictor of death in end-stage diabetic nephropathy: role of peripheral arterial disease. Kidney Int 2005; 68: 217-227.
-
(2005)
Kidney Int
, vol.68
, pp. 217-227
-
-
Boger, C.A.1
Gotz, A.2
Stubanus, M.3
Banas, B.4
Deinzer, M.5
Kruger, B.6
Holmer, S.R.7
Schmitz, G.8
Riegger, G.A.9
Kramer, B.K.10
-
19
-
-
0037277326
-
Early use of beta-blockers is associated with attenuation of serum C-reactive protein elevation and favorable short-term prognosis after acute myocardial infarction
-
Anzai T, Yoshikawa T, Takahashi T, Maekawa Y, Okabe T, Asakura Y, Satoh T, Mitamura H and Ogawa S. Early use of beta-blockers is associated with attenuation of serum C-reactive protein elevation and favorable short-term prognosis after acute myocardial infarction. Cardiology 2003; 99: 47-53.
-
(2003)
Cardiology
, vol.99
, pp. 47-53
-
-
Anzai, T.1
Yoshikawa, T.2
Takahashi, T.3
Maekawa, Y.4
Okabe, T.5
Asakura, Y.6
Satoh, T.7
Mitamura, H.8
Ogawa, S.9
-
20
-
-
0348110529
-
Endothelial function, inflammation, and prognosis in cardiovascular disease
-
Gonzalez MA and Selwyn AP. Endothelial function, inflammation, and prognosis in cardiovascular disease. Am J Med 2003; 115 Suppl 8A: 99S-106S.
-
(2003)
Am J Med
, vol.115
, pp. 99S-106S
-
-
Gonzalez, M.A.1
Selwyn, A.P.2
-
21
-
-
75049084220
-
Obesity, coffee consumption and CRP levels in postmenopausal overweight/obese women: importance of hormone replacement therapy use
-
Arsenault BJ, Earnest CP, Despres JP, Blair SN and Church TS. Obesity, coffee consumption and CRP levels in postmenopausal overweight/obese women: importance of hormone replacement therapy use. Eur J Clin Nutr 2009; 63: 1419-1424.
-
(2009)
Eur J Clin Nutr
, vol.63
, pp. 1419-1424
-
-
Arsenault, B.J.1
Earnest, C.P.2
Despres, J.P.3
Blair, S.N.4
Church, T.S.5
-
22
-
-
41549146350
-
Obesity and C-reactive protein levels among white, black, and hispanic US adults
-
Wee CC, Mukamal KJ, Huang A, Davis RB, McCarthy EP and Mittleman MA. Obesity and C-reactive protein levels among white, black, and hispanic US adults. Obesity (Silver Spring) 2008; 16: 875-880.
-
(2008)
Obesity (Silver Spring)
, vol.16
, pp. 875-880
-
-
Wee, C.C.1
Mukamal, K.J.2
Huang, A.3
Davis, R.B.4
McCarthy, E.P.5
Mittleman, M.A.6
|